Improvement in Quality of Life After Catheter Ablation for
Paroxysmal Versus Long-standing Persistent Atrial Fibrillation:
A Prospective Study With 3-Year Follow-up

J 2014

Improvement in Quality of Life After Catheter Ablation for Paroxysmal Versus Long-standing Persistent Atrial Fibrillation: A Prospective Study With 3-Year Follow-up

BULKOVÁ, Veronika; Martin FIALA; Štěpán HAVRÁNEK; Jan ŠIMEK; Libor ŠKŇOUŘIL et al.

Základní údaje

Originální název

Improvement in Quality of Life After Catheter Ablation for Paroxysmal Versus Long-standing Persistent Atrial Fibrillation: A Prospective Study With 3-Year Follow-up

Autoři

BULKOVÁ, Veronika; Martin FIALA; Štěpán HAVRÁNEK; Jan ŠIMEK; Libor ŠKŇOUŘIL; Jaroslav JANUŠKA; Jindřich ŠPINAR a Dan WICHTERLE

Vydání

Journal of the American Heart Association, Hoboken, Wiley-Blackwell, 2014, 2047-9980

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 4.306

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/14:00078476

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

atrial fibrillation; long-standing persistent; paroxysmal; quality of life

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 19. 1. 2015 11:53, Soňa Böhmová

Anotace

V originále

Background-Changes in quality of life (QoL) after catheter ablation for long-standing persistent atrial fibrillation (LSPAF) are not well described. We sought to compare QoL improvement after catheter ablation of paroxysmal atrial fibrillation (PAF) versus that after LSPAF. Methods and Results-A total of 261 PAF and 126 LSPAF ablation recipients were prospectively followed for arrhythmia recurrence, QoL, hospital stay, and sick leave. In PAF versus LSPAF groups, 1.3 +/- 0.6 versus 1.6 +/- 0.7 procedures were performed per patient (P<0.00001) during a 3-year follow-up. Good arrhythmia control was achieved in 86% versus 87% of patients (P=0.69) and in 69% versus 69% of patients not receiving antiarrhythmic drugs (P=0.99). The baseline QoL was better in the PAF than in the LSPAF group (European Quality of Life Group instrument self-report questionnaire visual analog scale: 66.4 +/- 14.2 versus 61.0 +/- 14.2, P=0.0005; European Quality of Life Group 3-level, 5-dimensional descriptive system: 71.4 +/- 9.2 versus 67.7 +/- 13.8, P=0.002). Postablation 3-year increase in QoL was significant in both groups (all P<0.00001) and significantly lower in PAF versus LSPAF patients (visual analog scale: +5.0 +/- 14.5 versus +10.2 +/- 12.8, P=0.001; descriptive system: +5.9 +/- 14.3 versus +9.3 +/- 13.9, P=0.03). In multivariate analysis, LSPAF, less advanced age, shorter history of AF and good arrhythmia control were consistently associated with postablation 3-year improvement in QoL. Days of hospital stay for cardiovascular reasons and days on sick leave per patient/year were significantly reduced in both groups. Conclusions-Patients with LSPAF had worse baseline QoL. The magnitude of QoL improvement after ablation of LSPAF was significantly greater compared with after ablation of PAF, particularly when good arrhythmia control was achieved without the use of antiarrhythmic drugs.

Citovat

BULKOVÁ, Veronika; Martin FIALA; Štěpán HAVRÁNEK; Jan ŠIMEK; Libor ŠKŇOUŘIL; Jaroslav JANUŠKA; Jindřich ŠPINAR a Dan WICHTERLE. Improvement in Quality of Life After Catheter Ablation for Paroxysmal Versus Long-standing Persistent Atrial Fibrillation: A Prospective Study With 3-Year Follow-up. Journal of the American Heart Association. Hoboken: Wiley-Blackwell, 2014, roč. 3, č. 4, s. "e000881", 15 s. ISSN 2047-9980. Dostupné z: https://doi.org/10.1161/JAHA.114.000881.

@article{1217417,
   author = {Bulková, Veronika and Fiala, Martin and Havránek, Štěpán and Šimek, Jan and Škňouřil, Libor and Januška, Jaroslav and Špinar, Jindřich and Wichterle, Dan},
   article_location = {Hoboken},
   article_number = {4},
   doi = {https://doi.org/10.1161/JAHA.114.000881},
   keywords = {atrial fibrillation; long-standing persistent; paroxysmal; quality of life},
   language = {eng},
   issn = {2047-9980},
   journal = {Journal of the American Heart Association},
   title = {Improvement in Quality of Life After Catheter Ablation for Paroxysmal Versus Long-standing Persistent Atrial Fibrillation: A Prospective Study With 3-Year Follow-up},
   volume = {3},
   year = {2014}
}

TY  - JOUR
ID  - 1217417
AU  - Bulková, Veronika - Fiala, Martin - Havránek, Štěpán - Šimek, Jan - Škňouřil, Libor - Januška, Jaroslav - Špinar, Jindřich - Wichterle, Dan
PY  - 2014
TI  - Improvement in Quality of Life After Catheter Ablation for Paroxysmal Versus Long-standing Persistent Atrial Fibrillation: A Prospective Study With 3-Year Follow-up
JF  - Journal of the American Heart Association
VL  - 3
IS  - 4
SP  - "e000881"
EP  - "e000881"
PB  - Wiley-Blackwell
SN  - 20479980
KW  - atrial fibrillation
KW  - long-standing persistent
KW  - paroxysmal
KW  - quality of life
N2  - Background-Changes in quality of life (QoL) after catheter ablation for long-standing persistent atrial fibrillation (LSPAF) are not well described. We sought to compare QoL improvement after catheter ablation of paroxysmal atrial fibrillation (PAF) versus that after LSPAF. Methods and Results-A total of 261 PAF and 126 LSPAF ablation recipients were prospectively followed for arrhythmia recurrence, QoL, hospital stay, and sick leave. In PAF versus LSPAF groups, 1.3 +/- 0.6 versus 1.6 +/- 0.7 procedures were performed per patient (P<0.00001) during a 3-year follow-up. Good arrhythmia control was achieved in 86% versus 87% of patients (P=0.69) and in 69% versus 69% of patients not receiving antiarrhythmic drugs (P=0.99). The baseline QoL was better in the PAF than in the LSPAF group (European Quality of Life Group instrument self-report questionnaire visual analog scale: 66.4 +/- 14.2 versus 61.0 +/- 14.2, P=0.0005; European Quality of Life Group 3-level, 5-dimensional descriptive system: 71.4 +/- 9.2 versus 67.7 +/- 13.8, P=0.002). Postablation 3-year increase in QoL was significant in both groups (all P<0.00001) and significantly lower in PAF versus LSPAF patients (visual analog scale: +5.0 +/- 14.5 versus +10.2 +/- 12.8, P=0.001; descriptive system: +5.9 +/- 14.3 versus +9.3 +/- 13.9, P=0.03). In multivariate analysis, LSPAF, less advanced age, shorter history of AF and good arrhythmia control were consistently associated with postablation 3-year improvement in QoL. Days of hospital stay for cardiovascular reasons and days on sick leave per patient/year were significantly reduced in both groups. Conclusions-Patients with LSPAF had worse baseline QoL. The magnitude of QoL improvement after ablation of LSPAF was significantly greater compared with after ablation of PAF, particularly when good arrhythmia control was achieved without the use of antiarrhythmic drugs.
ER  -

BULKOVÁ, Veronika; Martin FIALA; Štěpán HAVRÁNEK; Jan ŠIMEK; Libor ŠKŇOUŘIL; Jaroslav JANUŠKA; Jindřich ŠPINAR a Dan WICHTERLE. Improvement in Quality of Life After Catheter Ablation for Paroxysmal Versus Long-standing Persistent Atrial Fibrillation: A Prospective Study With 3-Year Follow-up. \textit{Journal of the American Heart Association}. Hoboken: Wiley-Blackwell, 2014, roč.~3, č.~4, s.~''e000881'', 15 s. ISSN~2047-9980. Dostupné z: https://doi.org/10.1161/JAHA.114.000881.

Přehled o publikaci